Navigation Links
Minnesota Nurses Association Endorses Steve Sarvi for Congress
Date:7/3/2008

ST. PAUL, Minn., July 3 /PRNewswire-USNewswire/ -- The Minnesota Nurses Association (MNA) announced today their endorsement of Steve Sarvi in his candidacy for U.S. House of Representatives, Congressional District 2.

"As a veteran of the Iraq war, Steve Sarvi will be the vigorous and informed advocate we need in Congress for meeting the healthcare needs of our returning soldiers," said MNA Political Committee Chair, Tom Kelly, RN. "With his unequivocal support of the Federal Staffing Bill, HR 2123, he has also recognized the need to improve the nurse's work environment which includes addressing safe and appropriate staffing."

Registered Nurses have long advocated for reforms vital to the improvement of health care and are demanding legislative action to change a health care system that does not safely serve sick Minnesotans. Nurses are calling on elected officials to recognize a staffing crisis and its impact on the lives and well-being of all those in their care.

"Right now, nurses are demanding that health care is reformed to put patient care ahead of market share, put nursing over numbers and people before profits," said MNA President, Linda Slattengren, RN. "On behalf of MNA we are pleased to endorse Mr. Sarvi and look forward to have him as the next elected congressman in support of Registered Nurses."

Unlike the Republican candidate in the House race, Mr. Sarvi has clearly demonstrated his commitment to implementing real change in the U.S. health care system to ensure high quality, affordable and accessible care. His health care platform incorporates important research that proves better RN staffing saves patient lives.

In addition to the endorsement of its 20,000 members, the Minnesota Nurses Association will forward a recommendation for Mr. Sarvi's endorsement to the American Nurses Association and the United American Nurses federal PACs.

Uniting nurses in vision and voice since 1905. With 20,000 members, MNA
'/>"/>

SOURCE Minnesota Nurses Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Minnesota Nurses Association Endorses Elwyn Tinklenberg for Congress
2. In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction
3. Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundations Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in Minnesota Participating
4. Minnesota, National Long Term Care Advocates: Pending Bush Medicare Cut Hurts States Rural Seniors
5. ExploreDairy.com Debuts With Information on Minnesota Dairy Events, People and Products
6. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
7. The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum
8. U of Minnesota researcher discovers the starting point of sun-induced skin cancer
9. National Business Group on Health Awards Gold to Blue Cross and Blue Shield of Minnesota for Promoting a Healthy Workplace
10. First Major Chinese Medical Delegation Visits Minnesota
11. ClearWay Minnesota(SM) Celebrates 10-Year Anniversary of Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...tion may have caused chromosomal change that raise...RIDAY, Aug. 29 (HealthDay News) -- Some Japanese s... Hiroshima and Nagasaki experienced key genetic ch... thyroid cancer, new research indicates. , Papi...a particular genetic mutation involving the so-cal...
(Date:8/29/2008)...LENWOOD, Ill., Aug. 29 /PRNewswire-FirstCall/ -- L... Board of Directors declared a regular,quarterly c...rter of fiscal,2008. The dividend will be paid on ...ember 12, 2008., About Landauer, Landauer is the...ine,occupational and environmental radiation expos...
(Date:8/29/2008)...CAGO Results of a 10-year study published in the ...icine found that magnesium sulfate administered t...duced the risk of cerebral palsy by 50 percent. Th...e (BEAM) trial was conducted in 18 centers in the ...first prenatal intervention ever found to reduce t...
(Date:8/29/2008)... http://www.aronowitzmd.com ..., has respected experience in plastic surgery proc...pecial consideration may be necessary for these pa...aff have an established specialty of procedures fo...s Angeles, CA (PRWEB) August 29, 2008 -- Bariatric...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4
... entered into an agreement with the National Resea...sing of Foot and Mouth Disease (FMD) vaccine devel...'As part of the agreement, we will produce and mar...irst. As and when we meet the requirements of the ...
...can reduce infant mortality rates, the Centre has ...mpaigns on breast feeding on the lines of the init...alone can reduce infant mortality rates by 13 per ...r the child but also ensures a strong foundation f...
...tients from different parts of India have begun ar...nalists have stepped up their campaign against the...a group of rationalists, has again urged the Andhr...ng the event, saying consumption of the 'drug' was...
...DNA has been discovered in mousetesticles. These a...to regulate key processes in human health //. RNA ...n shut off genesof the invading pathogens. Greg H...g Harbor Laboratory in New York and ThomasTuschl a...
Other Medicine News:Health News:'Fishy' Medicine Stirs Controversy 2Health News:'Fishy' Medicine Stirs Controversy 3
(Date:8/27/2008)...r Tonight in Parts of Bucks, Delaware, Montgomery,.../PRNewswire-USNewswire/ -- After encouraging,resul... the Department of,Environmental Protection will c...blic against the mosquito-borne West Nile virus., ...etween 8 p.m. and,midnight in portions of Bucks, D...
(Date:8/27/2008)...ized Pediatric Heart Center at The Children,s Hosp...y to Complete Range of Care and ...atric Cardiology Team Treats Every Heart Condition...e Children,s Hospital at,Montefiore (CHAM) is brin...lantation to the Bronx, following the recent appro...
(Date:8/26/2008)...Aug. 26 /- Semafore Pharmaceuticals I...ngress on Targeted Therapies,in Cancer in Washingt...targeted kinase inhibitors that demonstrate signif... A novel and proprietary molecular scaffold has b...g for the design of pan-PI3 kinase inhibitors,as w...
(Date:8/26/2008)...oupled with Innovative Manufacturing - Has Potenti... Preparedness, ROCKVILLE, Md., Aug. 26 /PRNewswir...ounced today favorable results from the second sta...pandemic influenza virus-like,particle (VLP) vacci...an,adjuvant, induced robust neutralizing antibody ...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Primates scent speaks volumes about who he is 3737 1Primates scent speaks volumes about who he is 3737 2Primates scent speaks volumes about who he is 3737 3American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic Resistant Staph Infections 22526 1American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic Resistant Staph Infections 22526 2American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic Resistant Staph Infections 22526 3American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic Resistant Staph Infections 22526 4American Academy of Dermatology Research Shows Athletes Susceptible to Antibiotic Resistant Staph Infections 22526 5Traumatic Brain Injuries Can Result From Senior Falls 22522 1Traumatic Brain Injuries Can Result From Senior Falls 22522 2Traumatic Brain Injuries Can Result From Senior Falls 22522 3One Gene May Be Key to Myeloma 22519 1One Gene May Be Key to Myeloma 22519 2One Gene May Be Key to Myeloma 22519 3
..., 2007 /PRNewswire/ -- Accera Inc.,announced today...,lead compound AC-1202 in Alzheimer,s disease (AD)...erican Academy of Neurology (AAN) in,Boston. Judge...program, the data will also be featured in the Sci...e president of clinical development Dr. Lauren,Cos...
...nt Pharmacokinetics With Reduced Risk,of Hypersens...5, 2007 /PRNewswire-FirstCall/ -- ADVENTRX,Pharmac...development company focused on commercializing pro...ancer and infectious diseases,today announced pos...ting of ANX-514 (docetaxel emulsion) in a well rec...
Other Medicine Technology:Accera, Inc. to Present Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting 2ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 2ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 3ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 4ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion) 5
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca
Khosla Precision and Quality in Medical and Surgical Products.
Khosla Precision and Quality in Medical and Surgical Products.
Electrical I/A unit for planned ECCE with peristaltic pump with linear aspiration (foot control). Independent irrigation, suction, reflux possible with multi-function footswitch that allows the surge
Medicine Products: